Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145


The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.

Bruehl S, Burns JW, Passik SD, Gupta R, Buvanendran A, Chont M, Schuster E, Orlowska D, France CR.

J Pain. 2015 Jul;16(7):666-75. doi: 10.1016/j.jpain.2015.04.001. Epub 2015 Apr 16.


Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.

Burns JW, Bruehl S, France CR, Schuster E, Orlowska D, Chont M, Gupta RK, Buvanendran A.

J Pain. 2017 Aug;18(8):923-932. doi: 10.1016/j.jpain.2017.02.439. Epub 2017 Mar 30.


Psychosocial factors predict opioid analgesia through endogenous opioid function.

Burns JW, Bruehl S, France CR, Schuster E, Orlowska D, Buvanendran A, Chont M, Gupta RK.

Pain. 2017 Mar;158(3):391-399. doi: 10.1097/j.pain.0000000000000768.


The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids.

Bruehl S, Burns JW, Morgan A, Koltyn K, Gupta R, Buvanendran A, Edwards D, Chont M, Kingsley PJ, Marnett L, Stone A, Patel S.

Pain. 2019 Mar;160(3):676-687. doi: 10.1097/j.pain.0000000000001447.


Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.

Bruehl S, Burns JW, Gupta R, Buvanendran A, Chont M, Kinner E, Schuster E, Passik S, France CR.

Pain. 2013 Sep;154(9):1856-64. doi: 10.1016/j.pain.2013.06.002. Epub 2013 Jun 6.


Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R), Current Opioid Misuse Measure (COMM)™, and provider gestalt.

Varney SM, Perez CA, Araña AA, Carey KR, Ganem VJ, Zarzabal LA, Ramos RG, Bebarta VS.

Intern Emerg Med. 2018 Dec;13(8):1239-1247. doi: 10.1007/s11739-018-1804-3. Epub 2018 Mar 3.


Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF.

Koyyalagunta D, Bruera E, Aigner C, Nusrat H, Driver L, Novy D.

Pain Med. 2013 May;14(5):667-75. doi: 10.1111/pme.12100. Epub 2013 Apr 30.


Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN.

J Pain. 2008 Apr;9(4):360-72. doi: 10.1016/j.jpain.2007.11.014. Epub 2008 Jan 22.


Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.

Bruehl S, Burns JW, Gupta R, Buvanendran A, Chont M, Schuster E, France CR.

Reg Anesth Pain Med. 2014 Mar-Apr;39(2):120-5. doi: 10.1097/AAP.0000000000000058.


Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study.

Finkelman MD, Smits N, Kulich RJ, Zacharoff KL, Magnuson BE, Chang H, Dong J, Butler SF.

Pain Med. 2017 Jul 1;18(7):1292-1302. doi: 10.1093/pm/pnw210.


Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R).

Butler SF, Zacharoff KL, Budman SH, Jamison RN, Black R, Dawsey R, Ondarza A.

Pain Med. 2013 Jul;14(7):1032-8. doi: 10.1111/pme.12098. Epub 2013 Apr 16.


Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain.

Chu LF, D'Arcy N, Brady C, Zamora AK, Young CA, Kim JE, Clemenson AM, Angst MS, Clark JD.

Pain. 2012 Aug;153(8):1583-92. doi: 10.1016/j.pain.2012.02.028. Epub 2012 Jun 16.


Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing.

Finkelman MD, Kulich RJ, Zacharoff KL, Smits N, Magnuson BE, Dong J, Butler SF.

Pain Med. 2015 Dec;16(12):2344-56. doi: 10.1111/pme.12864. Epub 2015 Jul 14.


A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department.

Weiner SG, Horton LC, Green TC, Butler SF.

Drug Alcohol Depend. 2016 Feb 1;159:152-7. doi: 10.1016/j.drugalcdep.2015.12.007. Epub 2015 Dec 21.


The optimal dose of prophylactic intravenous naloxone in ameliorating opioid-induced side effects in children receiving intravenous patient-controlled analgesia morphine for moderate to severe pain: a dose finding study.

Monitto CL, Kost-Byerly S, White E, Lee CK, Rudek MA, Thompson C, Yaster M.

Anesth Analg. 2011 Oct;113(4):834-42. doi: 10.1213/ANE.0b013e31822c9a44. Epub 2011 Sep 2.


Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.

Edwards RR, Wasan AD, Michna E, Greenbaum S, Ross E, Jamison RN.

J Pain. 2011 Sep;12(9):953-63. doi: 10.1016/j.jpain.2011.02.357. Epub 2011 Jun 16.


Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.

Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN.

Clin J Pain. 2007 May;23(4):307-15.


Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics?

Bruehl S, Burns JW, Gupta R, Buvanendran A, Chont M, Orlowska D, Schuster E, France CR.

Clin J Pain. 2017 Jan;33(1):12-20.

Supplemental Content

Support Center